Boston Medical Center (BMC) Grayken Center for Addiction Training and Technical Assistance (TTA)

A Resource for Healthcare and Social Services Professionals

Zeroing in on Xylazine

January 29, 2024
11:30 am–12:30 pm ET

This training will provide knowledge regarding xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US.

Please read the Accreditation Information section of this page to learn about the requirements for receiving credit or a certificate of completion.

Register now

Virtual meeting

Via Zoom

Description

This training will provide knowledge regarding xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US. This training will discuss the physiologic effects of xylazine, manifestations of xylazine intoxication, overdose, communicable infections associated with xylazine use, and wound care for persons injecting xylazine.

NOTE: This training is 60 minutes long. There will be an optional 30-minute Q&A session following the training, which will not count for credit. 

Intended audience

Providers, nurses, counselors, and other non-clinical staff are welcome to attend.

Speakers

Raagini Jawa, MD, MPH, FASAM (she/her)

Dr. Jawa is an Assistant Professor and Clinician Investigator in the Department of General Internal Medicine at University of Pittsburgh Medical Center and a clinician investigator in the Center for Research on Health Care. She is board certified in Internal Medicine and Infectious Disease and Addiction Medicine. Dr. Jawa’s research focuses on the intersection of Infectious Disease and Addiction, including studying how to optimize integration of harm reduction services for individuals with substance use disorders within traditional health settings, developing multidisciplinary provider facing interventions so as to prevent, diagnose, and treat infectious and non-infections complications of drug use. Clinically, she provides office-based addiction treatment in IM Recovery Engagement Program and attends on the Endovascular Infection Service at UPMC.

Tehya Johnson, NP

Teyha is a Nurse Practitioner working at the intersection of people experiencing homelessness and substance use disorders. She specializes in harm reduction, street outreach, and primary care based in Boston, MA, both as an advocate and a provider.

Objectives

Following this training, participants will have the knowledge necessary to: 

  1. Describe the physiologic effects of xylazine. 
  2. Recognize manifestations of intoxication in persons using xylazine.
  3. Recall signs of xylazine overdose and appropriate response.
  4. Identify common skin and soft tissue infections associated with xylazine use.
  5. Describe practices to decrease risk of skin and soft tissue infections in persons using xylazine.
  6. Recall methods of wound care for persons injecting xylazine.

Sponsored by

Boston Medical Center Grayken Center for Addiction TTA, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)

Funding for out of state attendees is provided by the Opioid Response Network (ORN).

Funding for this initiative was made possible (in part) by grant no. 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Accreditation information

REQUIREMENTS for credit

  1. Register for training.
  2. Arrive/log into the training no more than 10 minutes after designated start time for program.
  3. Identify yourself by typing your full name into the chat and ensuring your zoom name matches that used to register for training (or you cannot be marked on attendance).
  4. Be present through the end of the activity (i.e. until the designated end time of training).
  5. Complete evaluation within 2 weeks of program completion.

Please note this policy is strictly enforced for accreditation purposes. Participants will forfeit collection of credit and certificates of completion if more than 10 minutes of the training is missed.

Joint Accreditation Statement for Nursing and Social Work

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nurses

Nursing Contact Hours: 1.00 contact hours, of which 0.00 are eligible for pharmacology credit.

Social Workers

As a Jointly Accredited Organization, Boston University Chobanian & Avedisian School of Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.00 general continuing education credits.

Licensed Mental Health Counselors (LMHC)

BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs. For this program, 1.00 contact hours will be offered to participants who attend the training and complete the evaluation.

Alcohol and Drug Counselors (LADC/CADC)

Grayken Center for Addiction TTA is approved to offer LADC/CADCs who complete this course 1.00 general continuing education credits.

Recovery Coaches

Grayken Center for Addiction TTA is approved to offer recovery coaches who complete this course 1.00 general continuing education credits.

Disclaimer

Continuing education (CE) requirements vary by license and jurisdiction. When requesting continuing education credits, please ensure you are following the rules and regulations determined by the board regulating your license. Boston Medical Center Grayken Center for Addiction TTA does not oversee adherence to licensing requirements and regulations. 

THIS CONTINUING EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTHCARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.  NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.

Register now

Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.

Funding for Grayken Center for Addiction TTA is provided by:

Massachusetts Department of Public Health Bureau of Substance Abuse Services (BSAS)
GE Foundation
Opioid Response Network

The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.


© 2024 Boston Medical Center. All rights reserved. Site by Root802.